Current acellular pertussis vaccines prevent disease but do not prevent nasal infection and transmission of Bordetella pertussis. However, immunology is helping to design new vaccines that induce sterilizing immunity.
This is a preview of subscription content, log in via an institution to check access.
References
Warfel, J. M., Zimmerman, L. I. & Merkel, T. J. Proc. Natl Acad. Sci. USA 111, 787–792 (2014).
Wilk, M. M. et al. Emerg. Microbes Infect. 8, 169–185 (2019).
da Silva Antunes, R. et al. J. Clin. Invest. 128, 3853–3865 (2018).
Allen, A. C. et al. Mucosal Immunol. 11, 1763–1776 (2018).
Solans, L. et al. Mucosal Immunol. 11, 1753–1762 (2018).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author is an inventor on a patent around a new pertussis vaccine and receives research funding from and consults for vaccine manufacturers.
Rights and permissions
About this article
Cite this article
Mills, K.H.G. How immunology can help reverse the pertussis vaccine failure. Nat Immunol 24, 1779–1780 (2023). https://doi.org/10.1038/s41590-023-01625-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-023-01625-8
- Springer Nature America, Inc.